MA Dong, YANG Dong-yang. Phase Ⅲ Trial of Bevacizumab in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(3): 139-142. DOI: 10.3969/j.issn.1671-5144.2010.03.012
|
Citation:
|
MA Dong, YANG Dong-yang. Phase Ⅲ Trial of Bevacizumab in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(3): 139-142. DOI: 10.3969/j.issn.1671-5144.2010.03.012
|
MA Dong, YANG Dong-yang. Phase Ⅲ Trial of Bevacizumab in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(3): 139-142. DOI: 10.3969/j.issn.1671-5144.2010.03.012
|
Citation:
|
MA Dong, YANG Dong-yang. Phase Ⅲ Trial of Bevacizumab in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(3): 139-142. DOI: 10.3969/j.issn.1671-5144.2010.03.012
|
DownLoad: